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Preservation of a remote fear memory requires new myelin formation 
Simon Pan 
Abstract 
 
Experience-dependent myelination is hypothesized to shape neural circuit function and 
subsequent behavioral output. Using a contextual fear memory task in mice, we demonstrate 
that fear learning induces oligodendrocyte precursor cells (OPCs) to proliferate and differentiate 
into myelinating oligodendrocytes (OLs) in the medial prefrontal cortex (mPFC). Transgenic 
animals which cannot form new myelin exhibit deficient remote, but not recent, fear memory 
recall. Recording population calcium dynamics with fiber photometry, we observe that the 
neuronal response to conditioned context cues evolves over time in the mPFC, but not in 
animals that cannot form new myelin. Finally, we demonstrate that pharmacological induction of 
new myelin formation with clemastine fumarate improves remote memory recall and promotes 
fear generalization. Thus, bidirectional manipulation of myelin plasticity functionally impacts 
behavior and neurophysiology, suggesting that neural activity during fear learning instructs the 
formation of new myelin, which, in turn, supports the consolidation and/or retrieval of remote 
fear memories. 
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Chapter 1: Introduction 
The formation of enduring memories requires anatomical substrates that are both plastic, to 
represent new experiences, as well as perseverant, to preserve lasting representations of those 
experiences. Although the majority of myelination occurs during postnatal development, 
oligodendrocyte precursor cells (OPCs) persist in the adult brain and continually proliferate and 
differentiate to produce myelinating oligodendrocytes (OLs) throughout life1,2,3,4,5,6. OPCs exhibit 
excitatory postsynaptic potentials in response to neurotransmitter release7,8 and, in adult 
rodents, optogenetic or chemogenetic stimulation of neurons is sufficient to induce proliferation, 
differentiation, and maturation of cortical OPCs into myelinating OLs9,10,11. Naturalistic 
experiences such as motor learning, social isolation, environmental enrichment, and sensory 
deprivation are similarly able to regulate OPC proliferation and differentiation, raising the 
possibility that experience-induced myelin formation may represent an alternative, or additional, 
modality of structural remodeling during learning, distinct from synaptic plasticity12,4,13,14,15,16,17. 
Notably, studies monitoring the dynamics of OL populations over time through pulse-chase 
labeling or longitudinal in vivo two photon imaging report that myelinating OLs are 
extraordinarily stable upon formation, uniquely positioning new myelin formation as a durable 
substrate to support lifelong memories1,3,18. 
 
Myelination confers profound changes in the biophysical and molecular properties of axons, 
increasing transmembrane resistance, decreasing membrane capacitance, and coordinating 
architectural rearrangements of voltage-gated ion channels to enable rapid saltatory 
conduction19. Although it is well appreciated that myelination increases conduction velocity 
across individual axons, how this translates to computations at the level of neural circuits and 
their subsequent behavioral outputs is poorly understood20. Inhibition of new myelin formation 
prior to presenting adult mice to a complex wheel with missing rungs impairs motor learning, 
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demonstrating that new myelin formation is important for skilled learning15,17. However, it is not 
known what abnormalities in circuit activity underlie these behavioral deficits, nor whether these 
findings extend to other learning modalities, such as episodic and emotional memory, which are 
very distinct in their anatomical basis, mnemonic content, and clinical significance.  
 
Fear memory is a highly evolutionarily conserved behavior critical for evaluating and responding 
to threatening situations and can become pathologically maladaptive in neuropsychiatric 
diseases such as post-traumatic stress disorder (PTSD)21,22. Over time, fear memories become 
consolidated via a process involving reorganization of neuronal networks into a stable memory 
trace that can be recalled at least several weeks later, referred to as remote memory. While a 
number of studies have identified putative circuits that are involved in the consolidation of 
remote memories23,24,25,26,27. the cellular and synaptic mechanisms through which remote 
memories are consolidated, maintained, and retrieved remain an active area of 
investigation28,29. We found that contextual fear conditioning induced OPCs to proliferate and 
mature into myelinating OLs in the medial prefrontal cortex (mPFC). To examine the functional 
significance of this new myelin formation in fear learning, we assessed fear memory in 
transgenic mice that are unable to form new oligodendrocytes and found that remote fear 
memory recall was impaired in the absence of oligodendrogenesis. Furthermore, increasing 
new myelin formation through administration of the pro-myelinating compound clemastine 
fumarate preserved retrieval of remote fear memory. In both cases, immediate early gene 
expression in fear-associated brain regions paralleled the changes in learning performance. To 
probe this neurophysiological deficit with greater temporal resolution, we recorded population 
calcium dynamics in freely behaving mice via fiber photometry and observed altered prefrontal 
activity in the absence of new oligodendrogenesis during remote, but not recent, memory recall. 
Collectively, these findings suggest a reciprocal relationship in which learning experience 
induces new myelin formation that, in turn, supports the neural circuits of remote fear memories. 
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Chapter 2: Fear learning experience induces new myelin formation 
 
Fear learning experience induces OPC proliferation in the medial prefrontal cortex. 
To determine if fear learning induces OPC proliferation and differentiation, we injected wildtype 
8-week old male C57BL/6J mice with of 5-ethynyl-2’-deoxyuridine (EdU), a thymidine analogue 
that is incorporated by actively proliferating cells, and immediately subjected them to contextual 
fear conditioning (Figure 2.1a). 24 hours post-conditioning, conditioned mice froze in the 
conditioning context, indicative of successful learning of the shock-context association (Figure 
2.1b), and were then perfused for subsequent histological analysis. We detected an increase in 
the number of total EdU+ cells and EdU+/Olig2+ OPCs in the mPFC of conditioned mice 
compared to home cage controls (Figure 2.1c-f). As novel context exposure and the foot shock 
stress can conceivably induce these changes, we included two additional control groups in 
which the mice either received a context-only exposure (no shock; NS) or were shocked 
immediately upon being put in the chamber and promptly removed (immediate shock; IS). Both 
groups of mice displayed low levels of freezing during the retrieval session (Figure 2.1b), 
indicating the absence of learning, and correspondingly showed no changes in the number of 
EdU+/Olig2+ cells (Figure 2.1c-d). These results indicate that fear learning experience, 
independently of novel context exposure or foot shock stress, induces a rapid increase in OPC 
proliferation in the mPFC. 
 
Fear learning experience induces OPC maturation into myelinating OLs in the medial 
prefrontal cortex. 
Next, we determined if this brisk proliferation of OPCs culminated in their maturation to 
myelinating OLs. We conducted an extended experiment in which the mice were injected with 
EdU for five consecutive days and then fear conditioned, with their freezing responses 
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measured during retrieval sessions occurring 24 hours and 30 days post-conditioning (Figure 
2.2a). Freezing responses were maintained over the course of the experiment (Figure 2.2a) and 
the number of EdU+ cells co-localizing with ASPA, a marker for differentiated OLs, was 
increased in the mPFC with no change in the total amount of EdU+/Olig2+ cells (Figure 2.2c-e). 
Finally, we performed electron microscopy 30 days post-conditioning and found that fear 
learning experience significantly increased the density of myelinated axons in the mPFC of fear-
conditioned animals compared to home cage controls (Figure 2.2f-h).  
 
OPC maturation into myelinating OLs occurs over several weeks in adult gray matter. 
To examine the timing of OL maturation in adult gray matter, we quantified the density of 
EdU+/ASPA+ cells and GFP+/MBP+ (myelin basic protein) cells in the mPFC, BLA, and dHPC of 
tau-mGFPloxP/loxP;NG2CreERT+ mice that were injected with EdU for five consecutive days, fear 
conditioned, and then perfused after their 7, 14, or 30 day retrieval sessions (Figure 2.3a). In 
this line, membrane-bound GFP adjacent to a floxed stop codon is expressed under the tau 
promoter. NG2CreERT is an inducible cre line specific to OPCs, while the tau promoter is active 
in OLs but not OPCs. Thus, recombined OPCs that successfully differentiate into Ols are 
exclusively visualized by the expression of GFP. We can further distinguish mature, myelinating 
Ols from immature, non-myelinating Ols through the presence of distinctive myelin internodes 
that co-localize with MBP (Figure 2.3b-c). We observed that the density of EdU+/ASPA+ cells 
and GFP+/MBP+ cells was virtually zero in animals 7 days post-tamoxifen and -EdU but 
increased significantly at 14 and 30 days, while the density of GFP+/MBP- pre-myelinating OLs 
remained similar across time (Figures 2.3d-e).  
 
Next, we analyzed co-localization of ASPA, GFP, and MBP in tau-mGFPloxP/loxP;NG2CreERT+ 
animals perfused at 30 days and found that ASPA+/GFP+ cells were exclusively MBP+ OLs with 
myelinating morphology and conversely, that GFP+/MBP+ OLs with myelinating morphology 
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were exclusively ASPA+ (Figures 2.3f-g), demonstrating that ASPA is a specific marker for 
mature, myelinating OLs. These data suggest that although OPC proliferation and differentiation 
can occur rapidly, maturation and compact myelin formation in adult gray matter takes place 
over a prolonged timescale of several weeks. Importantly, the validation of ASPA as a marker of 
mature, myelinating OLs signifies that the increase in EdU+/ASPA+ cells in the mPFC that we 
observed in response to fear learning (Figure 2.2c-e) was indicative of new myelin formation. 
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Figure 2.1. Fear learning induces OPC proliferation in the mPFC. (a) Experimental 
paradigm for EdU injections and contextual fear conditioning. (b) Freezing responses pre-shock 
and during 24 hour recall for home cage (HC), fear conditioned (CFC), no shock (NS), and 
immediate shock (IS) groups; one-way ANOVA (F2,20 = 28.35, p < 0.0001) with Sidak’s post hoc 
tests comparing CFC vs. NS (difference: -31.19 ± 6.179, 95% CI: -44.54 to -17.84, p < 0.0001) 
and CFC vs. IS (difference -32.94 ± 5.536, 95% CI: -44.81 to -21.07, p < 0.0001). (c) Total EdU+ 
cell density in the mPFC of HC, CFC, NS, and IS animals; one-way ANOVA (F3,26 = 7.238, p = 
0.0012) with Sidak’s post hoc tests comparing HC vs. CFC (difference: -1.616 ± 0.5212, 95% 
CI: -2.946 to -0.2868, p = 0.0137), HC vs. NS (difference: 0.7080 ± 0.5382, 95% CI: -0.6654 to 
2.081, p = 0.4878), and HC vs. IS (difference: -0.1819 ± 0.5212, 95% CI: -1.512 to 1.148, p = 
0.9803). (d) EdU+/Olig2+ cell density in the mPFC of HC, CFC, NS, and IS animals; one-way 
ANOVA (F3,26 = 7.672, p = 0.0008) with Sidak’s post hoc tests comparing HC vs. CFC 
(difference: -1.393 ± 0.47, 95% CI: -2.592 to -0.1933, p = 0.0192), HC vs. NS (difference: 
0.7474 ± 0.4854, 95% CI: -0.4912 to 1.986, p = 0.3544), and HC vs. IS (difference: 0.1734 ± 
0.47, 95% CI: -1.026 to 1.373, p = 0.9769) at 24 hours post-conditioning. Representative 
images of EdU (green) and Olig2 (magenta) staining in the mPFC of home cage (e) and fear-
conditioned (f) animals, arrows indicate co-localized EdU+/Olig2+ cells; inset depicts separate 
color channels for representative EdU+/Olig2+ cells (top left).  For all panels, n = 7 mice (HC), 8 
mice (CFC), 7 mice (NS), 8 mice (IS). Scale bar: 50 μm. For box-and-whisker plots, the center, 
boxes, and whiskers represent the median, interquartile range, and the 10th and 90th percentiles, 
with asterisks indicating the following p-value ranges: * ≤ 0.05, **** ≤ 0.0001.  
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Figure 2.2. Fear learning experience induces OPC maturation into myelinating OLs in the 
mPFC. (a) Experimental paradigm for EdU injections and contextual fear conditioning. (b) 
Freezing responses during pre-conditioning and 24 hour and 30-day retrieval sessions; one-way 
ANOVA (F2,21 = 19.42, p < 0.0001) with Sidak’s post hoc tests comparing conditioning vs. 24 
hour (difference: -48.53 ± 9.402, 95% CI: -71.17 to -25.89, p < 0.0001) and conditioning vs. 30 
day (difference: -52.71 ± 9.402, 95% CI: -75.34 to -30.07, p < 0.0001). (c) EdU+/ASPA+ (left 
bars) and EdU+/Olig2+ (right bars) density in the mPFC of home cage (HC) and fear conditioned 
(CFC) animals at 30 days post-conditioning; unpaired two-tailed t-tests for HC vs. CFC for 
EdU+/ASPA+ (difference: 3.629 ± 1.125, 95% CI: 1.199 to 6.060, t13 = 3.226, p = 0.0066) and 
EdU+/Olig2+ (difference: 7.555 ± 6.944, 95% CI: -7.446 to 22.56, t13 = 1.088, p = 0.2963) cell 
density. Representative images of EdU (green) and ASPA (magenta) in the mPFC of home 
cage (d) and fear conditioned (e) animals, arrows indicate co-localized EdU+/ASPA+ cells; inset 
depicts separate color channels for representative EdU+/ASPA+ cell (left-most). (f) Quantification 
of myelinated axon density per field of view in the mPFC; unpaired two-tailed t-tests comparing 
HC vs. CFC (difference: 23.07 ± 5.882, 95% CI: 10.95 to 35.18, t25 = 3.922, p = 0.0006). 
Representative electron micrographs of myelinated axons (arrows) in mPFC gray matter for HC 
(g) and CFC (h) animals. (b-c) n = 7 mice (HC) and 8 mice (CFC), (f) n = 5 mice (HC) and 4 
mice (CFC), 3 fields of view per mouse. Scale bar: 50 (d-e) μm, (g-h) 2 μm. For box-and-
whisker plots, the center, boxes, and whiskers represent the median, interquartile range, and 
the 10th and 90th percentiles, with asterisks indicating the following p-value ranges: ** ≤ 0.01, *** 
≤ 0.001, **** ≤ 0.0001. 
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Figure 2.3. OPC maturation into myelinating OLs occurs over several weeks in adult gray 
matter. (a) Experimental paradigm for tamoxifen injections, EdU injections, contextual fear 
conditioning, and perfusions. Representative images of GFP+ (green)/MBP- (magenta) pre-
myelinating OLs at 7 days post-tamoxifen (b) and GFP+/MBP+ myelinating OLs (arrows) at 30 
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days post-tamoxifen (c) in the mPFC of fear conditioned mice; inset depicts separate color 
channels for representative GFP+/MBP+ cell (left-most). (d) Quantification of GFP+/MBP+ (left 
bars) and GFP+/MBP- (right bars) cell density in the mPFC over time; for GFP+/MBP+ density 
(left bars), one-way ANOVA (F2,19 = 6.586, p = 0.0067)  with Sidak’s post hoc tests comparing 7 
vs. 14 days (difference: -2.695 ± 1.070, 95% CI: -5.292 to -0.09785, p = 0.0614) and 7 vs. 30 
days (difference: -4.045 ± 1.129, 95% CI: -6.787 to -1.304, p = 0.004); for GFP+/MBP- density 
(right bars) one-way ANOVA (F2,21 = 0.07572, p = 0.9274) with Sidak’s post hoc tests  
comparing 7 vs. 14 days (difference: 2.354 ± 6.908, 95% CI: -14.41 to 19.12, p = 0.9308) and 7 
vs. 30 days (difference: 2.540 ± 7.292, 95% CI: -15.16 to 20.24, p = 0.9279). (e) EdU+/ASPA+ 
density in the mPFC over time; one-way ANOVA (F2,18 = 7.209, p = 0.005) with Sidak’s post hoc 
tests comparing 7 vs. 14 days (difference: -0.5957 ± 0.5125, 95% CI: -1.846 to 0.6543, p = 
0.4529) and 7 vs. 30 days (difference: -1.817 ± 0.4975, 95% CI: -3.031 to -0.6038, p = 0.0036). 
Representative images of GFP+/MBP+/ASPA+ myelinating OLs (f, arrows) and GFP+/MBP-
/ASPA- pre-myelinating OLs (g, arrowheads) in the mPFC at 30 days post-conditioning. For all 
panels, n = 6 mice (7 days), 9 mice (14 days), and 7 mice (30 days). Scale bars: 50 μm (b-c), 
10 μm (f-g). For box-and-whisker plots, the center, boxes, and whiskers represent the median, 
interquartile range, and the 10th and 90th percentiles, with asterisks indicating the following p-
value ranges: ** ≤ 0.01.  
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Chapter 3: Remote fear memory is impaired in the absence of new myelin 
formation 
 
Inhibition of new myelin formation impairs remote fear memory recall. 
As reported previously, conditional deletion of the transcription factor Myrf in OPCs arrests their 
differentiation and prevents the expression of myelin structural genes15,17,30. Administration of 
tamoxifen to adult MyrfloxP/loxP animals crossed with the NG2CreERT line therefore results in 
inhibition of oligodendrogenesis and new myelin formation while preserving existing myelinated 
circuits. We confirmed that this approach inhibits new myelin formation by examining the mPFC 
of MyrfloxP/loxP;tau-mGFPloxP/loxP;NG2CreERT+/- and MyrfloxP/+;tau-mGFPloxP/loxP;NG2CreERT+ 
littermates. 51 days post-tamoxifen, MyrfloxP/+;tau-mGFPloxP/loxP;NG2CreERT+ controls had many 
GFP+/MBP+ mature OLs with distinctive myelinating morphology, whereas the mPFC of 
MyrfloxP/loxP;tau-mGFPloxP/loxP;NG2CreERT+/- animals, with both copies of Myrf deleted, contained 
largely GFP+/MBP- pre-myelinating OLs (Figure 3.1c-d).  
 
We then generated cohorts of MyrfloxP/loxP;NG2CreERT+ and MyrfloxP/loxP;NG2CreERT- littermate 
controls (hereafter referred to as Myrf icKO and cre-negative controls) and subjected them to 
contextual fear conditioning three weeks following five consecutive days of daily tamoxifen 
administration, assessing their freezing responses at recent and remote time points (Figures 
3.1a). While both cre-negative and Myrf icKO animals exhibited high levels of freezing during 
recent retrieval sessions, context-elicited freezing responses in Myrf icKO mice declined over 
time and diverged from controls at 30 days post-conditioning, indicating a specific deficit in 
remote memory (Figures 3.1e). 
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To rule out the possibility that inhibition of basal myelin formation during the three weeks prior to 
conditioning has an effect on fear learning, we conducted identical fear conditioning 
experiments where we instead administered tamoxifen either five days pre-conditioning or just 
after 24 hour recall to solely inhibit new myelin formation during the consolidation period 
(Figures 3.1b). These Myrf icKO animals similarly exhibited a freezing deficit 30 days post-
conditioning, suggesting that it is new myelin formation during consolidation that is important for 
remote memory (Figures 3.1f). We then re-conditioned these animals by administering foot 
shocks in the original conditioning context 31 days post-conditioning. Both Myrf icKO and cre-
negative control animals exhibited high levels of freezing 24 hours following re-conditioning, 
demonstrating that there is no generalized impairment of freezing in Myrf icKOs at remote time 
points (Figure 3.1g). 
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Figure 3.1. Inhibition of new myelin formation impairs remote fear memory recall. 
(a) Experimental paradigm for contextual fear conditioning with tamoxifen administered three 
weeks pre-conditioning. (b) Experimental paradigm for contextual fear conditioning with 
tamoxifen administered five days prior and re-conditioning. (c) Representative images of GFP 
(green) and MBP (magenta) staining in the mPFC of MyrfloxP/+;tau-mGFPloxP/loxP;NG2CreERT+ 
(left, control) animals and in MyrfloxP/loxP;tau-mGFPloxP/loxP;NG2CreERT+ (right, Myrf icKO) animals 
30 days post-conditioning; inset depicts separate color channels for representative GFP+/MBP+ 
cell (top-most). (d) Quantification of GFP+/MBP+ cell density in the mPFC of control and Myrf 
icKO animals 30 days post-conditioning; n = 6 mice per condition (control, Myrf icKO), unpaired 
two-tailed t-test (difference: -5.806 ± 0.9062, 95% CI: -7.825 to -3.786, t10 = 6.406, p < 0.0001). 
Individual fear expression over time for Myrf icKO and control animals administered tamoxifen 
three weeks (e) and five days (f) prior to conditioning; (e) two-way ANOVA (F4,80 = 3.437, p = 
0.0121) with Sidak’s post hoc tests comparing cre-negative vs. Myrf icKO during conditioning 
(difference: -2.416 ± 5.790, 95% CI: -17.58 to 12.74, p = 0.9965), 24 hour (difference: -5.169 ± 
5.790, 95% CI: -20.33 to 9.991, p = 0.9040), and 30 day (difference: -24.37 ± 5.790, 95% CI: -
39.53 to -9.209, p = 0.0003), n = 11 mice per genotype; (f) two-way ANOVA (F4,80 = 1.435, p = 
0.2291) with Sidak’s post hoc tests comparing cre-negative vs. Myrf icKO during conditioning 
(difference 1.467 ± 7.398, 95% CI: -13.19 to 16.13, p = 0.8431), 24 hour (difference: 0.9199 ± 
7.398, 95% CI: -13.74 to 15.58, p = 0.9013), and 30 day (difference: 18.43 ± 7.398, 95% CI: 
3.767 to 33.09, p = 0.0142), n = 14 cre-negative and 10 Myrf icKO mice. (g) Freezing responses 
for Myrf icKO animals from cohort in (f) 24 hours after being re-conditioned 31 days post-
conditioning; paired two-tailed t-test (difference: 48.76 ± 6.624, 95% CI: 33.48 to 64.04, t8 = 
7.361, p < 0.0001). Scale bar: 50 μm. For box-and-whisker plots, the center, boxes, and 
whiskers represent the median, interquartile range, and the 10th and 90th percentiles. For dot 
plots, data are presented as mean ± SEM, with asterisks indicating the following p-value ranges: 
* ≤ 0.05, **** ≤ 0.0001.  
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Chapter 4: Fear-associated neurophysiology is abnormal in the absence of 
new myelin formation 
 
Immediate early gene expression following remote memory recall is impaired in the 
absence of new myelin formation 
To assess neuronal activity in response to remote memory recall, we perfused Myrf icKO and 
cre-negative control animals ninety minutes following the 30-day retrieval session and 
conducted histological analysis of Fos induction in a number of fear-associated brain regions. 
We found that the density of Fos+ cells was significantly decreased in the PL and IL of the 
mPFC, BLA, and dHPC of Myrf icKOs compared to cre-negative controls (Figure 4.1a, c-e), with 
the degree of Fos induction displaying a linear relationship with individual freezing at 30 days 
post-conditioning (Figure 4.1g-j). Notably, Fos induction was similar across genotypes in home 
cage controls at 30 days post-conditioning (Figure 4.1b) and following recent memory retrieval 
at 24 hours post-conditioning (Figure 4.1f). Fos+ cell density was also similar in a non-fear 
associated brain region, the somatosensory cortex (SSC), across genotypes (Figure 4.1a). This 
indicates that the physiological response of neurons within the fear memory network is 
specifically impaired in the absence of myelin formation during remote memory recall. 
 
Population calcium dynamics in the medial prefrontal cortex are altered in the absence of 
new myelin formation.  
In order to relate neuronal activity to freezing behavior in Myrf icKOs and cre-negative controls 
with high temporal resolution, we performed fiber photometry recordings in freely behaving mice 
during contextual fear conditioning and retrieval sessions (Figures 4.2a). We injected adeno-
associated viral (AAV) vectors expressing the calcium indicator GCaMP6f and implanted optical 
fibers at the PL/IL border of the mPFC (Figure 4.2b-c). This targeting effectively records from 
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the IL, where suppression of firing of mPFC units in response to conditioned cues has 
previously been reported31,32.  
 
Following recovery from the surgery, animals were administered tamoxifen for five days, rested 
for three weeks, and then subjected to contextual fear conditioning (Figure 4.2a). Both control 
and Myrf icKOs animals displayed robust neuronal responses to foot shock in the mPFC, with 
no difference in shock-evoked activity between genotypes (Figure 4.2d-e, h). To determine 
whether recall-induced neuronal activity was altered in the absence of new myelin formation, we 
aligned photometry signals to behavioral footage during retrieval sessions and analyzed the 
changes in mPFC activity during transitions from mobility to freezing. (Figure 4.2f-g). In line with 
previous reports conducting electrophysiological recordings of IL units 31,32, we found that, at 24 
hours post-conditioning, mPFC activity was suppressed during fear memory recall in both 
control and Myrf icKO animals (Figures 4.2g, 4.2i). However, we found that prefrontal dynamics 
associated with fear recall evolved over time in control animals, which exhibited an elevation of 
mPFC activity during transitions from mobility to freezing at 30 days post-conditioning (Figures 
4.2g, i). This time-dependent change in the recall-associated response was not evident in Myrf 
icKO animals, which continued to show a suppression of prefrontal activity during freezing 
transitions at 30 days post-conditioning (Figures 4.2g, i). The absence of this temporal evolution 
of prefrontal dynamics in Myrf icKO animals suggests that active oligodendrogenesis is required 
for remote fear memory consolidation. 
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Figure 4.1. Immediate early gene expression following remote recall is impaired in the 
absence of new myelin formation. (a) Quantification of Fos+ cell density across brain regions 
following 30-day retrieval sessions in Myrf icKO vs. cre-negative controls; unpaired two-tailed t-
tests, mPFC (difference: 84.27 ± 23.89, 95% CI: - 34.09 to 134.5, t21 = 3.528, p = 0.0024), BLA 
(difference: 80.55 ± 24.87, 95% CI: 28.66 to 132.4, t21 = 3.238, p = 0.0041), DG (difference: 
163.5 ± 55.29, 95% CI: 48.50 to 278.5, t21 = 2.957, p = 0.0075), CA3 (difference: 175.4 ± 63.83, 
95% CI: 42.70 to 308.2, t21 = 2.749, p = 0.012), SSC (difference: 21.86 ± 53.48, 95% CI: -89.35 
to 133.1, t21 = 0.4088, p = 0.6868), n = 12 cre-negative and 11 Myrf icKO mice. (b) 
Quantification of baseline home cage Fos+ cell density across brain regions in Myrf icKO vs. 
cre-negative controls; unpaired two-tailed t-tests, mPFC (difference: 4.591 ± 19.85, 95% CI: -
39.64 to 48.82, t10 = 0.2313, p = 0.8218), BLA (difference: -3.475 ± 25.49, 95% CI: -60.28 to 
53.33, t10 = 0.1363, p = 0.8943), DG (difference: -24.73 ± 56.36, 95% CI: -150.3 to 100.8, t10 = 
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0.4387, p = 0.6702), CA3 (difference: 11.42 ± 36.00, 95% CI: -68.79 to 91.63, t10 = 0.3172, p = 
0.7576), n = 6 mice per genotype. Representative images of Fos induction (cyan) in the mPFC 
(c), dHPC (d), and BLA (e) of cre-negative and Myrf icKO animals following 30-day retrieval. (f) 
Quantification of Fos+ density across brain regions following 24-hour retrieval sessions; 
unpaired two-tailed t-tests, mPFC (difference: -18.95 ± 25.61, 95% CI: -76.90 to 38.99, t9 = 0.74, 
p = 0.4781), BLA (difference: 41.33 ± 39.72, 95% CI: -48.53 to 131.2, t9 = 1.041, p = 0.3252), 
DG (difference: 64.80 ± 111.0, 95% CI: -186.2 to 315.8, t9 = 0.5839, p = 0.5736), CA3 
(difference: -45.58 ± 123.5, 95% CI: -324.9 to 233.7, t9 = 0.3692, p = 0.7205), n = 5 cre-negative 
and 6 Myrf icKO mice. Individual 30 day freezing responses plotted against Fos+ cell density in 
mPFC (g), BLA (h), DG (i), and CA3 (j); two-tailed Spearman’s correlation test, mPFC (Rs = 
0.589, 95% CI: 0.1853 to 0.8231, p = 0.0062), BLA (Rs = 0.467, 95% CI: 0.04322 to 0.7483, p = 
0.0284), DG (Rs = 0.451, 95% CI: 0.03545 to 0.7343, p = 0.305), CA3 (Rs = 0.535, 95% CI: 
0.1449 to 0.7812, p = 0.0085), n = 23 mice. Scale bars: 200 μm (c-e). Data are presented as 
mean ± SEM, with asterisks indicating the following p-value ranges: * ≤ 0.05, ** ≤ 0.01.  
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Figure 4.2. Prefrontal population calcium dynamics in the medial prefrontal cortex are 
altered in the absence of new myelin formation. (a) Experimental paradigm for surgeries, 
tamoxifen administration, and fiber photometry recordings during contextual fear conditioning 
and retrieval. (b) Schematic and anatomical location for delivery of calcium indicator and optical 
fiber and (c) representative image of GCaMP expression (green) and fiber placement in the 
mPFC. (d) Representative ΔF/F trace across a conditioning session with foot shocks overlaid in 
yellow. (e) Heatmap of ΔF/F values five seconds pre- and post-shock for the first shock 
delivered in five representative animals, color map represents ΔF/F. (f) Representative ΔF/F 
trace across a 24-hour retrieval session with freezing overlaid in blue. (g) Representative z-
scored ΔF/F traces across a time window spanning two seconds pre- and post-bout transition, 
from top to bottom: control, 24 hours; Myrf icKO, 24 hours; control, 30 days; Myrf icKO, 30 days. 
(h) Quantification of the mean ΔF/F during the five seconds pre- and post-shock, stratified by 
genotype; n = 14 bouts bouts/7 mice (control) and 6 bouts/3 mice (Myrf icKO); paired two-tailed 
t-tests comparing pre- and post-shock for control (difference: 0.08767 ± 0.007947, 95% CI: 
0.07051 to 0.1048, t13 = 11.03, p < 0.0001) and Myrf ickO (difference: 0.08468 ± 0.02609, 95% 
CI: 0.01760 to 0.1518, t5 = 3.245, p = 0.0031) animals; unpaired two-tailed t-test comparing post 
across genotypes (difference: 0.001432 ± 0.01574, 95% CI: -0.03163 to 0.03449, t18 = 0.09098, 
p = 0.9285). (i) Quantification of the difference between the z-scored mean ΔF/F of the two 
seconds pre- and post-bout transition for control and Myrf icKO animals, plotted during 24-hour 
(left bars) and 30-day (right bars) retrieval; n = 10 bouts for 7 mice (control) and 7 mice (Myrf 
icKO); unpaired two-tailed t-tests comparing across genotypes at 24 hour (difference -0.02001 ± 
0.1516, 95% CI: -0.3192 to 0.2792, t138 = 0.132, p = 0.8951) and 30 day (difference: -0.2963 ± 
0.07301, 95% CI: -0.4403 to -0.1524, t138 = 4.5059, p < 0.0001). Scale bar: 100 μm. For box-
and-whisker plots, the center, boxes, and whiskers represent the median, interquartile range, 
and the 10th and 90th percentiles, with asterisks indicating the following p-value ranges: n.s. (not 
significant) > 0.05, ** ≤ 0.01, **** ≤ 0.0001.  
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Chapter 5: Pharmacological induction of new myelin formation preserves 
remote fear memory 
 
Inducing new myelin formation preserves retrieval of a contextual fear memory 
Clemastine fumarate is an anti-muscarinic compound identified as a pro-myelinating agent in 
high throughput screening efforts to find therapeutics for demyelinating disease33,34. 
Administration of clemastine to humans and rodents with inflammatory demyelination promotes 
remyelination and relieves the severity of clinical symptoms35,36. Clemastine additionally 
promotes myelination and rescues behavioral deficits in mice that are hypomyelinated following 
either prolonged social isolation or chronic hypoxia36,37. To determine if induction of new myelin 
formation impacts fear memory, we subjected cohorts of wildtype 8-week old male C57BL/6J 
mice to contextual fear conditioning while injecting them daily with either clemastine or vehicle 
from 3 days pre- to 21 days post-conditioning (Figures 5.1a). We verified that chronic 
clemastine administration increases new myelin formation under healthy, physiological 
conditions by observing increased ASPA+ cell density and mean MBP fluorescence intensity in 
the mPFC of clemastine-treated mice (Figure 5.1b-d).  
 
Nonetheless, clemastine-treated mice displayed persistent and high freezing responses over 
time, suggesting that increasing new myelin formation stabilizes remote fear memory (Figure 
5.1e). To rule out the possibility that a remote memory phenotype is not simply a result of 
prolonged clemastine treatment, we administered daily clemastine for three weeks prior to 
conditioning and observed normal freezing behavior during recent memory recall (Figure 5.1f-g). 
Finally, we administered vehicle or clemastine injections to Myrf icKO mice and subjected them 
to the contextual fear learning paradigm (Figure 5.1h). In the absence of new myelin formation, 
clemastine-treated Myrf icKO animals appear identical to vehicle-treated animals (Figure 5.1i), 
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indicating that the effects of clemastine on fear memory are specifically dependent on new 
myelin formation. Collectively, these results indicate that inducing new myelin formation 
preserves remote fear memory, but may potentially decrease its precision.  
 
We then perfused vehicle- and clemastine-treated animals ninety minutes after the 30-day 
retrieval session for subsequent histological analysis of immediate early gene expression. Fos+ 
cell density was increased in clemastine-treated animals in the mPFC, BLA, and dHPC but not 
the SSC (Figure 5.2a-c). However, no differences in Fos induction were detected following 
recent memory recall in mice pre-treated with three weeks of clemastine, nor following remote 
memory recall in home cage mice that never learned the fear association (Figure 5.2d-e)  These 
results suggest that population neuronal activity in response to conditioned cues is increased in 
fear-associated brain regions following chronic clemastine administration.  
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Figure 5.1. Induction of new myelin formation preserves remote fear memory recall. (a) 
Experimental paradigm for clemastine injections and contextual fear conditioning. 
Representative images of ASPA (green) and MBP (gray) signal in the mPFC of vehicle- (b) and 
clemastine-treated (c) animals 30 days post-conditioning. (d) Quantification of ASPA+ cell 
density (left bars) and MBP mean fluorescence (right bars) in the mPFC of vehicle- and 
clemastine-treated animals; unpaired two-tailed t-tests comparing vehicle versus clemastine for 
ASPA+ density (difference: 156.9 ± 43.21, 95% CI: 67.00 to 246.7, t21 = 3.63, p = 0.0016) and 
MBP fluorescence (difference: 17.10 ± 5.640, 95% CI: 5.370 to 28.83, t21 = 3.032, p = 0.0063), n 
= 11 vehicle and 12 clemastine mice. (e) Individual fear expression over time for vehicle- and 
clemastine-treated animals; two-way ANOVA (F4,108 = 5.884, p = 0.0003) with Sidak’s post hoc 
tests comparing across treatment groups for conditioning (difference: 0.8941 ± 4.116, 95% CI: -
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9.860 to 11.65, p = 0.9928), 24 hour (difference: -0.8004 ± 4.116, 95% CI: -11.55 to 9.954, 
0.9948), and 30 day (difference: -17.49 ± 4.116, 95% CI: -16.00 to -0.3832, p = 0.0002), n = 15 
vehicle and 14 clemastine mice. (f) Experimental timeline controlling for the duration of 
clemastine injections, in which the entire injection protocol is completed prior to initiation fear 
conditioning and recent memory recall, n = 10 mice per treatment. (g) Individual freezing 
responses during recent memory recall testing for animals pre-treated with clemastine in 
experimental timeline (f); two-way ANOVA (F1,18 = 0.0003928, p = 0.9844). (h) Experimental 
paradigm for clemastine injections in Myrf icKO animals. (i) Individual fear expression over time 
for vehicle- and clemastine-treated Myrf icKO animals; two-way ANOVA (F4,48 =1.357, p = 
0.2629), n = 6 vehicle and 8 clemastine mice. Scale bars: 100 μm (b-c). Data are presented as 
mean ± SEM, with asterisks indicating the following p-value ranges: ** ≤ 0.01, **** ≤ 0.0001.  
 
Figure 5.2. Induction of new myelin formation increases immediate early gene expression 
following remote fear memory recall. (a) Quantification of Fos+ cell density across brain 
regions in vehicle- and clemastine-treated animals following 30-day retrieval; unpaired two-
tailed t-tests, mPFC (difference: 280.7 ± 54.50, 95% CI: 167.0 to 394.4, t19 = 5.15, p < 0.0001), 
BLA (difference: 75.06 ± 20.12, 95% CI: 32.95 to 117.2, t19 = 3.73, p = 0.0014), DG (difference: 
268.7 ± 56.69, 95% CI: 150.0 to 387.3, t19 = 4.739, p < 0.0001), CA3 (difference: 270.5 ± 77.34, 
95% CI: 109.2 to 431.8, t19 = 3.497, p = 0.0023), SSC (difference: 79.25 ± 55.73, 95% CI: -
38.33 to 196.8, t19 = 1.422, p = 0.1731), n = 13 vehicle and 8 clemastine mice. Representative 
images of Fos induction (cyan) in the mPFC (b) and dHPC (c) of vehicle- and clemastine-
treated animals following 30-day retrieval. (d) Quantification of Fos+ cell density across brain 
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regions in vehicle- and clemastine pre- treated animals, represented in Figure 7g-f, following 24 
hour retrieval; unpaired two-tailed t-tests, mPFC (difference: 6.885 ± 35.98, 95% CI: -68.71 to 
82.48, t18 = 0.1913, p = 0.8504), BLA (difference: -22.53 ± 17.11, 95% CI: -58.48 to 13.42, t18 = 
1.317, p = 0.2045), DG (difference: 3.547 ± 41.64, 95% CI: -83.94 to 91.04, t18 = 0.08518, p = 
0.9331), CA3 (difference: 5.178 ± 33.28, 95% CI: -64.74 to 75.10, t18 = 0.1556, p = 0.8781), n = 
10 mice per treatment group. (e) Quantification of Fos+ cell density across brain regions in home 
cage vehicle- and clemastine-treated animals, represented in Figure S6a, g, in the absence of 
fear learning; unpaired two-tailed t-tests, mPFC (difference: 10.88 ± 35.04, 95% CI: -62.73 to 
84.50, t18 = 0.3106, p = 0.7597), BLA (difference: -25.98 ± 22.03, 95% CI: -72.27 to 20.31, t18 = 
1.179, p = 0.2537), DG (difference: 26.58 ± 21.51, 95% CI: -18.61 to 71.77, t18 = 1.236, p = 
0.2324), CA3 (difference: -29.91 ± 29.50, 95% CI: -91.88 to 32.06, t18 = 1.014, p = 0.3239), n = 
10 mice per treatment group. Scale bars: 100 μm (b), 200 μm (c).  Data are presented as mean 
± SEM, with asterisks indicating the following p-value ranges: ** ≤ 0.01, **** ≤ 0.0001.  
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Chapter 6: Conclusion & future directions 
 
Conclusion 
In this study, we demonstrate that the generation of new oligodendrocytes is required for the 
proper functioning of neural circuits that mediate remote fear memory. This process is specific 
to remote memory, as Myrf icKO mice appear identical to cre-negative control animals at recent 
time points by many metrics, including freezing behavior, immediate early gene expression, and 
mPFC population calcium dynamics during both conditioning and recent retrieval sessions. 
Furthermore, these behavioral and neurophysiological deficits manifest after several weeks, 
suggesting that it is the formation of new myelin, which occurs over a timescale of weeks as we 
have described here, and not oligodendrocyte differentiation per se, which occurs over a 
timescale of hours17, that is important for remote fear memory recall. In addition to our electron 
microscopy analyses, we verify that in the healthy adult brain, ASPA is an exclusive marker for 
mature, myelinating OLs extruding MBP+ processes with characteristic morphology of compact 
myelin sheaths. Thus, we are able to demonstrate that fear learning induces the formation of 
bona fide new myelin in the prefrontal cortex. 
 
In two seminal studies, Myrf icKO mice displayed impairments in learning to run on a complex 
wheel as early as several hours into training. This rapid learning deficit was correlated with the 
immediate differentiation of OPCs into immature OLs within this same time window15,17. In 
contrast, the onset of deficits we have observed occurs much more slowly, reflecting the time 
required for compact myelin formation in the adult brain. Learning impairment on a more rapid 
timescale may conceivably be due to a loss of non-myelinating functions of OLs, such as 
metabolic support, neurotransmitter homeostasis, or clustering of voltage-gated ion 
channels39,40,41,42. Alternatively, the three-week interim between tamoxifen administration and 
  
24 
presentation of the complex wheel in which basal myelin formation is inhibited may impact 
learning performance independently of experience-induced OL production. In our study, we 
have presented evidence against the latter possibility by observing fear learning deficits in Myrf 
icKO animals administered tamoxifen both immediately prior to and after fear conditioning. 
 
Remote memory consolidation, or systems consolidation, involves a reorganization of memory 
networks, over the course of several weeks or longer, such that retrieval of a memory transitions 
from dependence on the hippocampus to distributed cortical ensembles over time28,29. However, 
the synaptic, cellular, and circuit-level mechanisms that underlie this process are not well 
understood. On the basis of lesioning studies, immediate early gene expression, and functional 
optogenetics experiments, the mPFC is thought to be particularly important for remote 
memory24,25,43,44. We affirm this in our experiments by recording from a population of neurons 
over the course of a month, as a memory transitions from recent to remote, and demonstrating 
that the population response of the mPFC to identical context cues evolves over time, which, to 
our knowledge, has not been achievable with traditional electrophysiological recording methods. 
These findings are consistent with miniaturized microscopy imaging of the mPFC during fear 
conditioning, which indicate that a small subset of shock-responsive cells elevate their firing 
rates 15 days post-conditioning when an animal is placed in the conditioned context25. 
Remarkably, this temporal evolution is not observed in the absence of new myelin formation, 
which, in conjunction with deficits in freezing behavior and immediate early gene expression 
specifically during remote recall, suggests that systems consolidation requires active 
myelination.  
 
We observe fear learning-induced changes in myelin content specifically in the mPFC but 
network-wide changes in immediate early gene expression, consistent with previous 
characterizations demonstrating that manipulating activity in a single node can have widespread 
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effects on fear memory circuits27. Although the mPFC is dispensable for recent memory, input 
from the entorhinal cortex and BLA to the mPFC at the time of conditioning is required for the 
initial establishment of neuronal ensembles that subsequently mature to mediate remote 
memory retrieval25. Here, we describe an analogous situation in which OPC proliferation in the 
mPFC is elicited immediately at the time of conditioning, but the ensuing maturation of 
myelinating OLs occurs over a prolonged period that is similar in length to the approximate 
timeline reported for systems consolidation. Notably, we detected an increase in post-training 
proliferation of OPCs in the BLA that did not translate to an increase in myelinating OLs several 
weeks later, suggesting that these OPCs may have differentiated but failed to mature. This is in 
accordance with longitudinal two photon imaging of OPC dynamics3 and suggests that, although 
memory acquisition is important to initiate this sequence of events, it is perhaps stable 
integration of maturing OLs during the consolidation period that is the important regulatory point 
in experience-dependent myelination.  
  
Future directions 
The mechanistic details of how new myelin formation acts to support remote memory is a salient 
question and requires a thorough understanding of how neuronal ensembles act in concert to 
achieve memory consolidation and retrieval. Though this remains an active area of research, 
several points appear to be true: 1) systems consolidation involves substantial interregional 
reorganization of neuronal networks in the form of neuronal engram ensembles24,25,28,43,44; 2) 
active interregional communication between brain regions separated in space, arbitrated by the 
myelinated axons of projection neurons, is required for both successful memory consolidation 
and retrieval24,25,27,45,46,47,48; 3) this interregional communication seems to be characterized by a 
high degree of temporal precision, particularly in the form of synchronized oscillatory 
activity,46,47. Thus, there are several conceivable ways through which new myelin formation can 
interact with or complement neural circuits to support systems consolidation and remote 
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memory retrieval. Myelination could be strengthening specific projections in a manner akin to 
Hebbian plasticity, facilitating communication between spatially distributed neuronal ensembles, 
and/or tuning axonal conduction velocities such that synchronized oscillations or other 
computationally relevant firing patterns can be achieved20,48. A recent study reported episodic 
memory deficits and disruptions in ripple-spindle coupling between the mPFC and dHPC 
several days after tamoxifen administration in Myrf icKO animals49. While the timing of these 
observations is much more rapid than the timeline required for new, compact myelin formation 
that we have described here, ripple-spindle coupling represents a fascinating example of a 
memory consolidation mechanism requiring temporally precise interregional coordination and 
active oligodendrogenesis47,49. Collectively, these results indicate that experience-dependent 
oligodendrocyte production may impact circuit function through multiple mechanisms and across 
different time scales. Distinguishing between and elaborating on these many potential scenarios 
represents a major technical challenge and will likely require the development of tools for 
region- or projection-specific manipulations of new myelin formation in conjunction with 
recordings of neuronal ensembles across multiple brain regions in freely behaving animals. 
 
In addition to establishing that remote fear memory requires new myelin formation, we 
demonstrate that induction of new myelin formation via clemastine enhances remote fear 
memory. As clemastine administration had no effect in Myrf icKO animals, this effect is likely 
dependent on new myelin formation. Notably, magnetic resonance imaging (MRI) examination 
of combat veterans with PTSD suggests increased hippocampal myelin content compared to 
combat-exposed controls, putatively implicating aberrant myelin formation in the 
pathophysiology of PTSD50. Although PTSD involves a constellation of symptoms, one of its 
prominent features is intense and overgeneralized fear responses21, which we have reproduced, 
to some degree, in mice chronically treated with clemastine. Indeed, a cardinal property of 
newly formed myelin is its stability, which may be desirable for retaining adaptive memories and 
  
27 
learned skills, but detrimental if maladaptive fear responses are persistent and generalized to 
everyday situations1,2,18.Thus, investigating the role of new myelin formation in adaptive and 
maladaptive learning constitutes an important opportunity both for understanding, diagnosing, 
and potentially treating PTSD and other neuropsychiatric illnesses, and for elucidating 
fundamental mechanisms of learning and memory. 
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Chapter 7: Materials & Methods   
  
Mice 
MyrfloxP/loxP (JAX: 010607) mice were crossed to the NG2-CreERT (JAX: 008538) line to 
generate MyrfloxP/loxP; NG2-CreERT (Myrf icKO) mice. These lines were maintained through 
crosses of MyrfloxP/loxP;NG2CreERT+ and MyrfloxP/loxP; NG2CreERT+ breeders, generating 
MyrfloxP/loxP;NG2CreERT+ and MyrfloxP/loxP; NG2CreERT- littermates on a mixed 129; CBA/J; 
C57BL/6J background. To validate inhibition of new myelin formation following Myrf deletion, 
triple transgenic MyrfloxP/loxP;tau-mGFPloxP/loxP (JAX: 21162);NG2CreERT+ and MyrfloxP/+;tau-
mGFPloxP/loxP;NG2CreERT+ male and female littermates were generated through crosses of 
MyrfloxP/loxP;tau-mGFPloxP/loxP;NG2CreERT+ and MyrfloxP/+;tau-mGFPloxP/loxP;NG2CreERT- breeders. 
Cre-mediated recombination was induced via daily intraperitoneal injections of 20 mg/ml 
tamoxifen (Sigma-Aldrich) dissolved in 10% ethanol/90% peanut oil for five consecutive days, at 
a dose of 80 mg/kg. Mice were rested for either three weeks or five days before beginning 
subsequent behavioral experiments. Tau-mGFPloxP/loxP;NG2CreERT+ mice on a C57BL/6J 
background were maintained through crosses of tau-mGFPloxP/loxP;NG2CreERT+ and tau-
mGFPloxP/loxP;NG2CreERT- breeders. All transgenic mice used in this study were littermates 
aged 8 - 10 weeks at the start of experiments. Males and females were used in approximately 
equal numbers and age-matched littermates were randomly assigned to cohorts. Genotyping 
was performed as recommended on the Jackson Laboratories datasheet for each mouse line 
via standard polymerase chain reaction of tail-derived genomic DNA. Sequences for all 
genotyping primers are detailed in the key resources table. 
 
Clemastine experiments in Figures 7-8 and 5-ethynyl-2’-deoxyuridine (EdU) experiments in 
Figures 1-2 were conducted with 8-week old male C57BL/6J mice (JAX: 000664). Clemastine 
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fumarate (AvaChem Scientific) was prepared as a 1 mg/ml solution in 10% dimethyl sulfoxide 
(DMSO; Sigma)/phosphate-buffered saline (PBS) and administered via daily intraperitoneal 
injection at a dose of 10 mg/kg, alternating injection sites each day. Vehicle controls were 
injected in an identical manner with 10% DMSO/PBS. EdU (Carbosynth) was prepared as a 10 
mg/ml solution in PBS and administered via intraperitoneal injection at a dose of 80 mg/kg. 
 
All animals were group-housed with one to four same-sex cagemates in standard rodent cages 
within a pathogen-free barrier facility on a 12-hour light/dark cycle, with behavioral testing and 
recordings performed during the light phase.  Food and water were available ad libitum and 
cages were changed on a biweekly basis by veterinary technicians. All procedures were pre-
approved by and conducted in accordance with the U.S. NIH Guide for the Care and Use of 
Laboratory Animals and the Institutional Animal Care and Use Committees at the University of 
California, San Francisco. 
 
Behavior 
Conditioned fear was elicited by administering three mild footshocks (0.75 mA), spaced thirty 
seconds apart, following a five-minute exposure to an array of contextual cues (conditioning 
chamber, chamber lights, white noise, scent of anise extract). Retrieval of the fear memory was 
assessed by re-exposure of the animal to the conditioning context in the absence of shock, and 
freezing, the cessation of all movement outside of respiration, was interpreted as expression of 
fear memory. Video recordings were acquired and scored automatically in FreezeFrame 
(Actimetrics). Mice were habituated to transport and holding in a separate room for at least one 
hour prior to all conditioning or retrieval sessions. For assessment of Fos induction following 
fear memory retrieval, habituation was extended to four hours and all animals were perfused 
exactly 90 minutes after the start of the retrieval session. For assessment of generalization, 
freezing was measured in a context similar to the conditioning context but with the following 
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variations: chamber lights and fan were turned off, scent of anise extract was swapped for 
lemon extract, and a plastic divider was inserted to make the chamber walls circular and 
opaque. Freezing in the similar context was tested two hours following retrieval testing in the 
original conditioning context, and animals were rested in a holding room between sessions. For 
the immediate shock condition, one 0.75 mA footshock was administered thirty seconds after 
context exposure, followed by immediate removal of the animal from the chamber. 
 
Anxiety-like behaviors were assessed via the open field test (OFT) and elevated plus maze 
(EPM). Video recordings were acquired in Ethovision (Noldus) and time spent in the periphery 
of the OFT and in the closed arms of the EPM were scored through automated object detection, 
and interpreted as anxiety-like behavior. Freezing and anxiety-like behaviors were both scored 
via an automated, unbiased process and thus were not explicitly performed blinded. 
 
Fiber photometry 
Recombinant adeno-associated virus (AAV; AAV1.hSyn.GCaMP6f.WPRE.SV4051; Addgene) 
was stereotactically injected unilaterally into the right mPFC (+1.7 mm AP, +0.35 mm ML, -
2.75/2.5/2.25/2.0 mm DV, 150 nl per injection site) of male MyrfloxP/loxP;NG2CreERT+/- and 
MyrfloxP/loxP; NG2CreERT-/- littermates. 400 μm diameter and 2.2 mm length optical fibers 
encased in stainless steel ferrules (Doric) were implanted directly above the injection site (-1.9 
mm DV) within the same surgery. After recovery from surgery over several days, mice were 
administered a five-day tamoxifen regimen. Three weeks following surgery, animals were 
habituated to the patch cord (Doric) for thirty minutes for three consecutive days, and subjected 
to contextual fear conditioning as previously described. Fiber photometry recordings of mPFC 
calcium dynamics were acquired during each conditioning or retrieval session using the 
Synapse software suite (Tucker-Davis Technologies) and a hardware setup consisting of an 
RZ5P fiber photometry processor (Tucker-Davis Technologies), 405 nm and 465 nm LED 
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excitation (Doric), a 6-port fluorescence mini cube (Doric), and photoreceiver module (Doric). 
465 nm and 405 nm LED excitation were sinusoidally modulated at 210 Hz and 330 Hz, 
respectively. Patch cord autofluorescence was bleached overnight prior to every recording 
session via continuous LED illumination. A five-minute baseline recording in the home cage was 
acquired just prior to each conditioning or retrieval session. All animals were perfused for post 
hoc histology following their final recording session to verify viral expression and implant 
placement. One animal was excluded from fiber photometry analysis due to incorrect fiber 
placement. 
 
Immunohistochemistry 
Animals were perfused with PBS followed by 4% (w/v) paraformaldehyde (PFA) in PBS. Intact 
brains were extracted and post-fixed in 4% PFA overnight at 4°C. The tissue was then 
cryoprotected in 30% (w/v) sucrose (Sigma) in PBS, sectioned at 30 μm on a sliding microtome 
(Leica), and stored as floating sections in PBS containing 0.02% sodium azide. For 
immunohistological analysis, brain sections were blocked in 10% goat or donkey serum in PBS 
containing 0.1 % (v/v) Triton X-100 (PBST) for 1 - 2 hours at room temperature (RT). Primary 
antibodies were diluted in blocking solution and incubated overnight at 4°C and secondary 
antibodies were diluted in PBS and incubated for two hours at RT. The primary antibodies used 
in this study and their working concentrations are as follows: rabbit monoclonal anti-GFP 
(ThermoFisher Cat#G10362, 1:1000), chicken polyclonal anti-GFP (Aves Labs Cat#GFP-1020, 
1:1000), rabbit polyclonal anti-Olig2 (Millipore Cat#AB9610, 1:1000), rabbit polyclonal anti-
ASPA (Sigma-Aldrich Cat#ABN1698, 1:1000), rat monoclonal anti-MBP (Serotec 
Cat#MCA409S, 1:200), goat polyclonal anti-Fos (Santa Cruz Antibodies Cat#sc-52-G, 1:500), 
rabbit polyclonal anti-Iba1 (Wako Cat#019-19741, 1:1000). 
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EdU incorporation by proliferating cells was detected via copper-catalyzed click chemistry with a 
picolyl azide conjugated to a 488 Alexa Fluor dye (Click Chemistry Tools). For co-labeling with 
immunohistochemical staining, free-floating brain sections were incubated with a reaction mix 
consisting of 488 picolyl azide (5 μM), CuSO4 (Sigma-Aldrich, 4 mM), and sodium ascorbate 
(Acros, 100 mM) in PBS for 30 minutes at RT, between the blocking and primary antibody 
incubation steps. 
 
Electron microscopy 
8-week old male C57BL/6J mice were subjected to contextual fear conditioning and perfused 30 
days post-conditioning with 2% (w/v) PFA/1.25% (w/v) glutaraldehyde in 0.1M sodium 
cacodylate buffer. Intact brains were extracted and post-fixed in 2% PFA/1.25% glutaraldehyde 
overnight at 4°C. The brains were then cryoprotected in 30% (w/v) sucrose (Sigma) in PBS and 
sectioned coronally at 500 μm on a sliding microtome (Leica). Sections containing the mPFC 
were then further cut by hand approximately along the dashed lines represented in Figure S1k, 
and sent to the University of California, San Francisco Pathology Electron Microscopy Core 
facility for further processing and transmission electron microscopy imaging. Briefly, tissue was 
post-fixed in 2% osmium tetroxide in 0.1M sodium cacodylate buffer, stained with 2% aqueous 
uranyl acetate, dehydrated in ethanol, cleared in propyline oxide, and embedded in Eponate 12 
(Ted Pella Co). Ultra-thin sections were then collected, beginning from the medial margin, to 
sample the superficial cortical layers. The sections were subsequently stained with uranyl 
acetate and Reynold’s lead and examined using a Tecnai 10 transmission electron microscope 
(Philips). The presence of myelinated axons is highly variable in gray matter, and so in order to 
emphasize the regions of the mPFC with substantial myelin content, we subsampled the three 
fields of view, per animal, with the highest density of myelinated axons. 
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Fiber photometry analysis 
Freezing behavior during fiber photometry experiments was scored manually in a blinded 
manner via The Observer (Noldus) as automated scoring was incompatible with movement of 
the patch cord. Photometry signals were manually aligned to freezing behavior via a light pulse 
that was output by FreezeFrame and detected by an internally aligned video recording. ΔF/F 
was calculated by subtracting the linear fit of the isobestic signal to the raw GCaMP signal from 
the raw GCaMP signal, and then dividing the subsequent result by the linear fit of the isobestic 
signal to the raw GCaMP signal; i.e., (465raw - 405fitted) / (405fitted). Z-scored ΔF/F values were 
then computed using the mean and standard deviation of the entire recording session. Peri-
event analysis was centered on the transitions from bouts of mobility to bouts of freezing that 
each lasted at least two seconds. The ΔF/F values were extracted from two seconds pre- and 
post-transition (referred to as pre and post) and the pre mean and post mean are the mean z-
scored ΔF/F values within the two seconds pre- and post-bout transition. Peri-event analysis for 
shock responses were computed similarly, comparing the mean ΔF/F within the five seconds 
pre- and post-shock. 
 
Histological quantification 
All images were acquired with a CSU-W1 spinning disk confocal microscope (Nikon Imaging 
Center, UCSF. For the basolateral amygdala (BLA) and dorsal hippocampus (dHPC), the entire 
structure, per hemisection, was quantified as one field. Two fields were quantified manually per 
section using the multipoint tool in ImageJ, using two to three averaged sections per mouse. 
Absolute cell counts were normalized to the quantified area and reported as cellular density 
(cells/mm2). Myelin basic protein (MBP) fluorescence intensity was quantified by averaging the 
mean gray value from the Measure function in FIJI51. from three non-overlapping fields per brain 
region per section, with two to three averaged sections per mouse. All comparisons of MBP 
fluorescence intensity were conducted on sections stained and imaged within the same 
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sessions, with identical exposure settings used during acquisition. For quantification of 
GFP+/MBP+ myelinating OLs, either cell bodies or non-overlapping GFP+/MBP+ arbors were 
counted as individual cells, with occasional ambiguous cases conservatively quantified as a 
single cell. All image quantifications were conducted in a blinded manner. 
 
Statistical analysis 
No statistical methods were used to predetermine sample size a priori, but the sample sizes 
used are similar to those used in previous studies15,17. Two-way ANOVA was used to probe for 
significant interactions of genotype with freezing behavior across contextual fear conditioning 
experiments, with Sidak’s post hoc tests to make single comparisons between genotypes at 
specific time points. Single comparisons of histological quantifications and fiber photometry 
parameters were performed via a two-tailed student’s t-test; paired two-tailed t-tests were used 
for within animal comparisons and unpaired t-tests were used for comparisons between 
genotypes or treatment conditions. Comparisons of histological quantifications or freezing 
behavior between three or more groups or time points were performed with one-way ANOVA 
with Sidak’s post hoc tests. Prism 6 (GraphPad) and MATLAB (Mathworks) were used for all 
statistical analyses. Data distribution was assumed to be normal but this was not formally 
tested. For all dot plots and differences reporting, data are presented as mean ± SEM. For all 
box-and-whisker plots, the center represents the median, the boxes represent the interquartile 
range, and the whiskers represent the 10th and 90th percentile. Sample sizes and statistical tests 
used are indicated in the figure legends, with symbols indicating the following p-value ranges: 
n.s. (not significant) > 0.05, * ≤ 0.05, ** ≤ 0.01, *** ≤ 0.001, **** ≤ 0.0001.  
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